Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crosscut Ventures is a private, Los Angeles-based early-stage venture capital firm that invests primarily in frontier technology companies rather than operating as a drug developer, biotech, pharma, or healthcare company. The firm was founded in 2008 and describes itself as the first and longest-enduring early-stage venture capital firm in Los Angeles. Its current investment focus centers on energy transition, decarbonization, space, defense, advanced manufacturing, robotics, and related industrial technologies. Crosscut provides capital as well as company-building support, founder development, and operational guidance to seed and Series A-stage startups. For a biotech analyst, Crosscut is best understood as an investor that may occasionally back health-related startups, but it is not itself a life sciences operating company with a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crosscut Ventures.